Evidence map›Paper›PMID 31554749›Full record

ArticleExperimental animals2020

Genetic mutation of Frem3 does not causeFraser syndrome in mice.

Daiji Kiyozumi, Masashi Mori, Mayo Kodani, Masahito Ikawa

Open access · diamondAbstract read
In one paragraph

Article in Experimental animals, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Daiji KiyozumiResearch Institute for Microbial Diseases, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Masashi MoriResearch Institute for Microbial Diseases, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Mayo KodaniResearch Institute for Microbial Diseases, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Masahito IkawaResearch Institute for Microbial Diseases, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Microbial Chemistry Research Foundation · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

QBRICK, FRAS1, and FREM2 compose a family of extracellular matrix proteins characterized by twelve consecutive CSPG repeats and single or multiple Calx-β motifs. Dysfunction of these proteins have been associated with Fraser syndrome, which is characterized by malformation of skin, eyes, digits, and kidneys. FREM3 is another member of the 12-CSPG protein family. However, it remains unknown whether genetic dysfunction of FREM3 also causes Fraser syndrome or another developmental disorder. Here we investigated a Frem3 mutant mouse line generated by CRISPR/Cas9-mediated genome editing. The FREM3 mutant homozygotes were born at the expected Mendelian ratio and did not possess any defects characteristic of Fraser syndrome. These results indicate that the dysfunction of FREM3 is not associated with Fraser syndrome.

Indexed as

MutationAnimalsExtracellular Matrix ProteinsFraser SyndromeMiceExtracellular Matrix ProteinsFrem3 protein, mouseBifid Nose Renal Agenesis and Anorectal malformations (BNAR)CRISPR/Cas9Fraser syndromeFrem3Manitoba-oculo-tricho-anal syndrome (MOTA).

Identifiers

PMID31554749
PMCPMC7004800
OpenAlexW2976880167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.